40 Hz auditory steady-state response and EEG spectral edge frequency during sufentanil anaesthesia

Canadian Journal of Anaesthesia

Volumn 45, Issue 2, 1998, Pages 115-121

  Gilron, I ^a,b,c   Plourde, G ^b,d   Marcantoni, W ^b   Varin, F ^a,c  

^a DTP Clinical Trials Unit   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MIDAZOLAM; PANCURONIUM; SUFENTANIL; VECURONIUM;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; ELECTROENCEPHALOGRAM; EVOKED AUDITORY RESPONSE; FEMALE; GENERAL ANESTHESIA; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0031920322     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03013248     Document Type: Article

References (17)

1. Stapells DR, Linden D, Suffield JB, Hamel G, Picton TW. Human auditory steady state potentials. Ear Hear 1984; 5: 105-13.
2. Plourde G. Clinical use of the 40-Hz auditory steady state response. Int Anesthesiol Clin 1993; 31: 107-20.
3. Plourde G, Boylan JF. The auditory steady state response during sufentanil anaesthesia. Br J Anaesth 1991; 66: 683-91.
4. Chi OZ, Sommer W, Jasaitis D. Power spectral analysis of EEG during sufentanil infusion in humans. Can J Anaesth 1991; 38: 275-80.
5. Scott JC, Cooke JE, Stanski DR. Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil. Anesthesiology 1991; 74: 34-42.
6. Fuseau E, Sheiner LB. Simultaneous modelling of pharmacokinetics and pharmacodynamics with nonparametric pharmacodynamic model. Pharmacol Ther 1984; 35: 733-11.
7. Holford NHG, Sheiner LB. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Phamacokinet 1981; 6: 429-53.
8. Electrode Position Nomenclature Committee. Guideline thirteen: guidelines for standard electrode position nomenclature. J Clin Neurophysiol 1994; 11: 111-3.
9. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical Recipes in C. The Art of Scientific Computing, 2nd ed. Cambridge: Cambridge University Press, 1992.
10. Snyder AZ. Steady-state vibration evoked potentials: description of technique and characterization of responses. Electroencephalogr Clin Neurophysiol 1992; 84: 257-68.
11. Kirk RE. Experimental Design: Procedures for the Behavioral Sciences, 2nd ed. Belmont, California: Brooks/Cole Publishing Company, 1982.
12. Olson CL. Statistics. Making Sense of Data. Dubuque, Iowa: Wm. C. Brown Publishers, 1988.
13. Michiels M, Hendriks R, Heykants J. Radioimmunoassay of the new opiate analgesics alfentanil and sufentanil. Preliminary pharmacokinetic profile in man. J Pharm Pharmacol 1983; 35: 86-93.
14. Bouyer JJ, Montaron MF, Rougeul A. Fast fronto-parietal rhythms during combined focused attentive behaviour and immobility in cat: cortical and thalamic localizations. Electroencephalogr Clin Neurophysiol 1981; 51: 244-52.
15. Sheer DE. Sensory and cognitive 40-Hz event-related potentials: behavioral correlates, brain function, and clinical application. In: Basar E, Bullock TH (Eds.). Brain Dynamics. Progress and Perspectives. Berlin: Springer-Verlag, 1989: 339-74.
16. Brown CR, Sarnquist FH, Canup CA, Pedley TA. Clinical, electroencephalographic, and pharmacokinetic studies of water-soluble benzodiazepine, midazolam maleate. Anesthesiology 1979; 50: 467-70.
17. Rutherford JD, Braunwald E. Chronic ischemic heart disease. In: Braunwald E (Ed.). Heart Disease. A Textbook of Cardiovascular Medicine, 4th ed. Philadelphia: W.B. Saunders, 1992: 1292-364.